• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并糖尿病性增殖性视网膜病变的妊娠

Pregnancies complicated by diabetic proliferative retinopathy.

作者信息

Lauszus F F, Grøn P L, Klebe J G

机构信息

Gynecological and Obstetrical Unit, Dept. Y, Skejby Hospital, Aarhus, Denmark.

出版信息

Acta Obstet Gynecol Scand. 1998 Sep;77(8):814-8.

PMID:9776594
Abstract

BACKGROUND

To examine retinal and pregnancy outcome in insulin-dependent diabetic women with proliferative retinopathy and assess the effect of albuminuria on morbidity.

METHODS

The records of 26 women with known proliferative retinopathy before pregnancy were studied retrospectively in the prepregnancy period, during pregnancy, and after delivery. Perinatal and maternal morbidity was studied using ophthalmic, obstetric and pediatric records.

RESULTS

Seven pregnancies were delivered preterm (27%). Serious neonatal morbidity occurred in five pregnancies (19%). Perinatal survival was 88%. Laser treatment was given prior to pregnancy to 54%, during pregnancy to 27% and after delivery to 31% of the women. Laser treatment during pregnancy was more common in those with no prior photocoagulation and in White class F/R. Low birthweight was more frequently associated with nephropathy and proliferative retinopathy compared to retinopathy alone (p<0.05). Recent hemorrhage, maculopathy or glaucoma was found in 14 (54%) of the women. Blindness developed unilaterally in two women.

CONCLUSIONS

Perinatal morbidity was associated with nephropathy rather than retinopathy. The incidence of hemorrhage, maculopathy or glaucoma was similar in White classes R and F/R.

摘要

背景

研究胰岛素依赖型糖尿病合并增殖性视网膜病变女性的视网膜及妊娠结局,并评估蛋白尿对发病率的影响。

方法

对26例妊娠前已知患有增殖性视网膜病变的女性记录进行回顾性研究,涵盖妊娠前期、妊娠期及产后。通过眼科、产科及儿科记录研究围产期及孕产妇发病率。

结果

7例妊娠早产(27%)。5例妊娠发生严重新生儿发病率(19%)。围产期存活率为88%。54%的女性在妊娠前接受激光治疗,27%在妊娠期接受治疗,31%在产后接受治疗。妊娠期激光治疗在未接受过光凝治疗者及White F/R级中更为常见。与单纯视网膜病变相比,低出生体重与肾病及增殖性视网膜病变的关联更为频繁(p<0.05)。14例(54%)女性发现近期出血、黄斑病变或青光眼。2例女性单侧失明。

结论

围产期发病率与肾病而非视网膜病变相关。White R级和F/R级中出血、黄斑病变或青光眼的发生率相似。

相似文献

1
Pregnancies complicated by diabetic proliferative retinopathy.合并糖尿病性增殖性视网膜病变的妊娠
Acta Obstet Gynecol Scand. 1998 Sep;77(8):814-8.
2
[Diabetic retinopathy and nephropathy--complications in pregnancy and labor].糖尿病视网膜病变与肾病——妊娠及分娩期并发症
Geburtshilfe Frauenheilkd. 1995 May;55(5):275-9. doi: 10.1055/s-2007-1023317.
3
Association of diabetic maculopathy with diabetic nephropathy--a study.糖尿病黄斑病变与糖尿病肾病的关联——一项研究
J Indian Med Assoc. 2002 Sep;100(9):567-8.
4
[Preliminary results of laser coagulation of the retina in the treatment of diabetic retinopathy in pregnant women].[激光凝固视网膜治疗妊娠糖尿病性视网膜病变的初步结果]
Klin Oczna. 1992 May-Jun;94(5-6):147-8.
5
Retinal and pregnancy outcomes in the presence of diabetic proliferative retinopathy.
J Reprod Med. 1994 Oct;39(10):799-804.
6
Vascular complications in diabetic pregnancy.糖尿病妊娠中的血管并发症。
Thromb Res. 2009;123 Suppl 2:S1-3. doi: 10.1016/S0049-3848(09)70001-5.
7
Pregnancy and complicated diabetes.妊娠与复杂糖尿病
Br J Hosp Med. 1993;49(10):739-42.
8
Vascular complications in diabetic pregnancy.糖尿病孕妇的血管并发症。
Thromb Res. 2011 Feb;127 Suppl 3:S53-5. doi: 10.1016/S0049-3848(11)70015-9.
9
Impact of pregnancy on complications of insulin-dependent diabetes mellitus.妊娠对胰岛素依赖型糖尿病并发症的影响。
Am J Perinatol. 1988 Oct;5(4):359-67. doi: 10.1055/s-2007-999723.
10
Survey of glargine use in 115 pregnant women with Type 1 diabetes.115例1型糖尿病孕妇的甘精胰岛素使用情况调查。
Diabet Med. 2008 Feb;25(2):165-9. doi: 10.1111/j.1464-5491.2007.02339.x. Epub 2008 Jan 19.

引用本文的文献

1
Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.患有糖尿病的女性的糖尿病肾病:从妊娠计划到母乳喂养
Curr Diab Rep. 2016 Feb;16(2):12. doi: 10.1007/s11892-015-0705-3.